TMED vs. LFSC
TMED (T. Rowe Price Health Care ETF) and LFSC (F/m Emerald Life Sciences Innovation ETF) are both Health & Biotech Equities funds. A 0.67 correlation means they provide meaningful diversification when combined. TMED charges 0.44%/yr vs 0.54%/yr for LFSC.
Performance
TMED vs. LFSC - Performance Comparison
Loading charts...
Returns By Period
The year-to-date returns for both stocks are quite close, with TMED having a 3.87% return and LFSC slightly lower at 3.84%.
TMED
- 1D
- 1.04%
- 1M
- 2.47%
- YTD
- 3.87%
- 6M
- 4.17%
- 1Y
- —
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
LFSC
- 1D
- 1.08%
- 1M
- -1.63%
- YTD
- 3.84%
- 6M
- 1.68%
- 1Y
- 58.79%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
TMED vs. LFSC - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
TMED T. Rowe Price Health Care ETF | 3.87% | 18.92% |
LFSC F/m Emerald Life Sciences Innovation ETF | 3.84% | 48.24% |
Correlation
The correlation between TMED and LFSC is 0.67, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (All Time) Calculated using the full available price history since Jun 13, 2025 | 0.67 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
TMED vs. LFSC — Risk / Return Rank
TMED
LFSC
TMED vs. LFSC - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and F/m Emerald Life Sciences Innovation ETF (LFSC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.
Loading charts...
Sharpe Ratios by Period
| TMED | LFSC | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | — | 2.28 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 1.35 | 1.07 | +0.28 |
Drawdowns
TMED vs. LFSC - Drawdown Comparison
The maximum TMED drawdown since its inception was -11.11%, smaller than the maximum LFSC drawdown of -29.74%. Use the drawdown chart below to compare losses from any high point for TMED and LFSC.
Loading charts...
Drawdown Indicators
| TMED | LFSC | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -11.11% | -29.74% | +18.63% |
Max Drawdown (1Y)Largest decline over 1 year | — | -16.25% | — |
Current DrawdownCurrent decline from peak | -2.75% | -3.57% | +0.82% |
Average DrawdownAverage peak-to-trough decline | -2.59% | -7.82% | +5.23% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | — | 5.82% | — |
Volatility
TMED vs. LFSC - Volatility Comparison
Loading charts...
Volatility by Period
| TMED | LFSC | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | — | 7.43% | — |
Volatility (6M)Calculated over the trailing 6-month period | — | 18.52% | — |
Volatility (1Y)Calculated over the trailing 1-year period | 18.04% | 26.01% | -7.97% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 18.04% | 28.90% | -10.86% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 18.04% | 28.90% | -10.86% |
TMED vs. LFSC - Expense Ratio Comparison
TMED has a 0.44% expense ratio, which is lower than LFSC's 0.54% expense ratio.
Dividends
TMED vs. LFSC - Dividend Comparison
TMED's dividend yield for the trailing twelve months is around 0.52%, while LFSC has not paid dividends to shareholders.
| Position | TTM | 2025 |
|---|---|---|
LFSC F/m Emerald Life Sciences Innovation ETF | 0.00% | 0.00% |
TMED T. Rowe Price Health Care ETF | 0.52% | 0.54% |
Frequently Asked Questions
TMED and LFSC have a correlation of 0.67, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.
TMED is cheaper with a 0.44% expense ratio, compared with 0.54% for LFSC.
TMED has the higher dividend yield at 0.52%, compared with 0.00% for LFSC.
They also come from different issuers: T. Rowe Price and F/m Investments. Their fees differ too: 0.44% for TMED and 0.54% for LFSC.
Find the right allocation for TMED and LFSC
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer